MTOR and neoplasm: Recently, more specific, molecularly targeted drugs have been developed that block specific tumor cell survival pathways, such as mTOR-mediated pathway inhibitors [6,7], targeting the cell cycle and metabolism [8,9], and those affecting the tumor microenvironment, such as immunotherapies.